Yokohama, Kanagawa Prefecture, Japan Related Funds
| Fund Name | Location |
| 13 Ventures | Charlottesville, United States, Virginia |
| ABB | Switzerland, Zürich, Zurich |
| Cobis | Great Falls, United States, Virginia |
| Coinsilium Group | England, London, United Kingdom |
| Echo Capital | Canada, Montréal, Quebec |
| Gabriel Capital Management | New York, New York, United States |
| Good Seed Ventures | Germany, North Rhine-Westphalia, Rheine |
| Guangzhou Yihe Investment | - |
| Guolian Group | China, Jiangsu, Wuxi Shi |
| Kettle Partners | Chicago, Illinois, United States |
| Luoji Siwei | Beijing, Beijing, China |
| Macromedia | California, San Francisco, United States |
| Madison Development Corporation | Madison, United States, Wisconsin |
| Mingxin China Growth Fund | Beijing, Beijing, China |
| Remarkable | - |
| Starharbor Asia | - |
| TPG Growth | California, San Francisco, United States |
| Xinlan Investment | Beijing, Changping, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GEXVal | $6M | 10 Sep 2021 | Fujisawa, Kanagawa Prefecture, Japan | ||
GEXVal | $3M | 17 Jul 2018 | Fujisawa, Kanagawa Prefecture, Japan | ||
SymBio Pharmaceuticals | $18M | 27 Jun 2006 | Chiyoda, Japan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GEXVal | $6M | 10 Sep 2021 | Fujisawa, Kanagawa Prefecture, Japan | ||
GEXVal | $3M | 17 Jul 2018 | Fujisawa, Kanagawa Prefecture, Japan | ||
SymBio Pharmaceuticals | $18M | 27 Jun 2006 | Chiyoda, Japan |
